Optimal Collaborative Management of Patients With Esophagogastric Cancers
Presented by David Ilson,(1) MD, PhD, and Steve Malangone,(2) MSN, FNP-C, AOCNP®
(1)Memorial Sloan Kettering Cancer Center, New York, New York; (2)University of Arizona Cancer Center, Tucson, Arizona
Presenters’ disclosures of potential conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2017;8:237–242 |
© 2017 Harborside Press®
The addition of radiation to preoperative chemotherapy and newer therapeutic combinations add to treatment options for these difficult-to-treat cancers.
For access to the full length article, please sign in